Published • loading... • Updated
JAK Inhibitors Associated with Increased Acne Risk in Atopic Dermatitis
Summary by Deutsches Ärzteblatt
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Boston – In adults with atopic dermatitis, the initiation of therapy with a low-dose Januskinase (JAK) inhibitor may be associated with a higher risk of acne than the initiation of treatment with a Th2 cytokin inhibitor. This is reported by a working group from Brigham and Women's Hospital and Harvard Medical School in Boston.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
